Navigation Links
AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF
Date:11/15/2007

As Vaccine Efforts Stumble, Millions Remain Without AIDS Treatment

Worldwide

LOS ANGELES, Nov. 15 /PRNewswire-USNewswire/ -- For the second time in two weeks, clinical researchers working to develop an AIDS vaccine have announced that their efforts have stumbled or, in the case of Merck -- outright failed -- after Merck's AIDS vaccine trial was halted last week when its vaccine was suspected of actually making some study participants more susceptible to contracting HIV. These latest shortcomings in the increasingly elusive search for a safe and effective AIDS vaccine underscore the need to focus on promoting HIV prevention and scaling up the delivery of lifesaving antiretroviral treatment (ART), both proven and existing strategies, to help keep people around the world from becoming infected, or for those already living with HIV/AIDS, alive and well, said AIDS Healthcare Foundation (AHF).

Earlier today, Reuters reported that " ... another experimental AIDS vaccine may damage the immune system by exhausting key cells ... a finding that may further cloud the field of HIV vaccines." Reuters noted that the researchers, who published their findings in the 'Journal of Clinical Investigation' said that, " ... vaccines using the viruses should not be tested on people until more studies are done," and that, " ... In mice, the adeno-associated virus, or AAV vaccines, directly interfered with immune cells called CD8 T-cells ... the 'killer' T-cells that a vaccine is supposed to muster to fight HIV."

"Development of a safe and effective AIDS vaccine is a clearly a noble and worthy goal; however, the sad truth remains that more than 40 million people worldwide are living with HIV/AIDS today, yet barely two million of them have access to lifesaving antiretroviral AIDS treatments," said Michael Weinstein, AIDS Healthcare Foundation President. "Treatments that actually do work and help keep those fortunate enough to have access to them alive and well. Treatments, which also have also been around, and continually improved, for over a decade. These recent failures in vaccine development underscore just how tenuous the quest for an AIDS vaccine remains, and reminds us of what effective, but underused tools, including antiretroviral treatment, we already have available to us today. While we long for the day when there is an effective preventive AIDS vaccine, we also call for a reevaluation of the distribution of limited government resources in the battle against AIDS, and renew our call for a greatly stepped-up worldwide commitment to bringing antiretroviral treatment to many, many more of those 38 million people still in need."

About AHF

AIDS Healthcare Foundation (AHF) is the US' largest non-profit HIV/AIDS healthcare, research, prevention and education provider. AHF currently provides medical care and/or services to more than 61,000 individuals in 18 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at http://www.aidshealth.org


'/>"/>
SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... Facing medical needs with a newborn boy ... advantage of a new benefit for employees that is uncommon in American business: 12 ... company supports me and other employees as new parents. It keeps our family life ...
(Date:7/25/2017)... ... ... SignatureCare Emergency Center – South Austin is treating both adult and pediatric patients ... The Emergency Room opened early March, making it the first SignatureCare Emergency ... are running smoothly,” said Aaron Braun, SignatureCare Emergency Center’s Chief Medical Officer. “We’re glad ...
(Date:7/24/2017)... ... July 24, 2017 , ... Contact: ... Robins & Morton, Perkins Will, Newcomb & Boyd, Walter P Moore and ... new Destination Medical Building located at Mayo Clinic in Jacksonville, Florida. , ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... SignatureCare ... scholarship will be awarded for the fall semester to a deserving student. Get ... Centers Spring 2017 scholarship was awarded to Mariana Castillo who is a nursing student ...
(Date:7/24/2017)... ... July 24, 2017 , ... BayMark Health Services has been ... Administration’s (SAMHSA) State Targeted Response to the Opioid Crisis program. The funding, ... the development of a hub and spoke model for opioid treatment in California. ...
Breaking Medicine News(10 mins):
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., the ... testing, strengthening and rehabilitation equipment, today announced the national ... MedX is considered the gold standard for the treatment ... specialized medical strengthening equipment. ... with the physician or practice who prescribe the MedX ...
(Date:7/13/2017)... 13, 2017 RK Logistics Group, Inc. was awarded ... for its Fremont, CA headquarters facility ... Tri-Valley and San Jose for hi-tech, ... Fremont , with its Fremont Innovation District, is excited ... a powerful resource to the hundreds of biotech, pharma and ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
Breaking Medicine Technology: